Bilibili (BILI.US) Latest News & Headlines | Longbridge

Weekly Recap | Bilibili +2.04%, most brokers rate it buy
Weekly Review·Sep 12 at 07:51 AM
- Bilibili shares rose 2.04 % over the week to close at 15.54 USD, outperforming the S & P 500 by 2.84 percentage points. - The company announced a 700 million USD convertible bond issuance and Tencent's share placement, which institutions believe removed selling pressure. - Thirty-one institutions currently cover Bilibili, with twenty-eight giving buy or overweight ratings and an average target price of 26.83 USD.
BILI-1.78%
Weekly Recap | Bilibili -8.25%, consensus target above spot
Weekly Review·Sep 5 at 06:15 AM
- Bilibili shares fell 8.25 % over the week to close at 15.23 USD on Friday, underperforming the S&P 500 index. - Major institutional developments included Goldman Sachs reducing its long position, BlackRock increasing its stake, and the company announcing a 700 million USD convertible senior notes offering alongside equity placement and share buybacks. - Despite the downward price trend and a new 52-week low, the consensus rating remained strong buy with an average target price of 27.28 USD.
BILI-1.78%
Weekly Recap | Bilibili -2.7%, consensus target above spot
Weekly Review·Aug 29 at 05:18 AM
- Bilibili cumulative fell 2.7 % this week to close at 16.6 dollars, underperforming the S & P 500 by 3.19 percentage points. - The second-quarter net revenue reached 7.94 billion yuan with a 55 % year-on-year increase in net profit, while 32 institutions maintain a consensus strong buy rating with a target price of 27.88 dollars. - Market focus shifts to upcoming US macroeconomic data and the execution pace of the company's new game pipeline.
BILI-1.78%
Weekly Recap | Bilibili -2.18%, consensus target sits above spot
Weekly Review·Aug 22 at 04:45 AM
- Bilibili ( BILI.US ) fell 2.18 % this week to close at 17.06 USD, underperforming the S & P 500 by 0.75 percentage points amidst broader market and US-listed Chinese stock pressures. - Thirty-two institutions currently cover the company with an aggregate "Strong Buy" consensus rating and a consensus target price of 29.79 USD, indicating significant upside potential from current levels. - The upcoming second-quarter financial results for fiscal year 2026, scheduled for August 27, will serve as a crucial catalyst for verifying its commercialization progress and earnings improvement.
BILI-1.78%